SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for ProPhase Labs, Inc. (PRPH) (CIK 0000868278) (PRPH) — Apr 24, 2009

ProPhase Labs, Inc. (PRPH) (CIK 0000868278)
Date: April 24, 2009 · CIK: 0000868278 · Accession: 0000000000-09-021871

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Referenced dates: April 16, 2009

Date
April 24, 2009
Author
Peggy Kim
Form
UPLOAD
Company
ProPhase Labs, Inc. (PRPH) (CIK 0000868278)

Letter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549-0303 DIVISION OF CORPORATION FINANCE Mail Stop 3628 April 24, 2009 By Facsimile and U.S. Mail Aron Izower, Esq. Reed Smith LLP 599 Lexington Avenue 22 nd Floor New York, NY 10012 Re: Quigley Corporation Revised Proxy Statement on Schedule 14A filed by Ted Karkus et al. Filed April 21, 2009 File No. 0-21617

Dear Mr. Izower:

We have reviewed your filings and have the following co mments. Where indicated, we think you should revise your document in response to these comments. If you disagree, we will consider your explanation as to why a comment is inapplicable or a revision is unnecessary. Please be as detailed as necessa ry in your explanation. In some of our comments, we may ask you to provide us with supplemental informati on so we may better understand your disclosure. After reviewing this information, we ma y or may not raise additional comments.

Please understand that the purpose of our re view process is to assist you in your compliance with the applicable disclosure requir ements and to enhance the overall disclosure in your filings. We look forward to working with you in these respects. We welcome any questions you may have about our comments or any other aspect of our review. Feel free to call us at the telephone numbers listed at the end of this letter. Schedule 14A

1. We note your response to comment one in our letter dated April 16, 2009. Please advise us as to how your notice of intern et availability complies with the requirements in Rule 14a- 16. For example, it does not appear to contai n all of the information required by Rule 14a- 16(c)(1) and contains supporting statements when Rule 14a-16(c)(3) specif ically states that no supporting statements be included. Please refer to Rule 14a-16 and SEC Release No. 34-56135 in your analysis.

Aron Izower, Esq. Quigley Corporation April 24, 2009 Page 2 Reasons for the Solicitation, page 2

2. We note your response to comment six in our letter dated April 16, 2009. Please revise your disclosure to include the support for your statements. 3. We note that the participants collectively own over 10% of th e shares outstanding. Please revise to include the information requ ired by Item 405 of Regulation S-K and corresponding Item 7(b) of Schedule 14A. Proposal One—Election of Directors, page 4

4. We note your statement that one or more Shareholder Nominees qualify as an audit committee financial expert. Please revi se to identify these individuals. What is a quorum, page 11

5. We note your response to comment 12 in our le tter dated April 16, 2009. Please revise to clearly state the effect of broker non-votes and abstentions on the quorum requirement.

Please direct any questions to me at ( 202) 551-3411. You may also contact me via facsimile at (202) 772-9203. Please send all correspondence to us at the following ZIP code: 20549-3628. Sincerely, Peggy Kim S p e c i a l C o u n s e l Office of Mergers & Acquisitions

Show Raw Text
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549-0303

       DIVISION OF
CORPORATION FINANCE

Mail Stop 3628

April 24, 2009

By Facsimile and U.S. Mail

Aron Izower, Esq. Reed Smith LLP 599 Lexington Avenue 22
nd Floor
New York, NY 10012
Re:   Quigley Corporation  Revised Proxy Statement on Schedule 14A  filed by Ted Karkus et al.
Filed April 21, 2009 File No. 0-21617

Dear Mr. Izower:

We have reviewed your  filings and have the following co mments.  Where indicated, we
think you should revise your document in response to these comments.  If you disagree, we will
consider your explanation as to why a comment is inapplicable or a revision is unnecessary.
Please be as detailed as necessa ry in your explanation.  In some  of our comments, we may ask
you to provide us with supplemental informati on so we may better understand your disclosure.
After reviewing this information, we ma y or may not raise additional comments.

 Please understand that the purpose of our re view process is to assist you in your
compliance with the applicable disclosure requir ements and to enhance the overall disclosure in
your filings.  We look forward to working with  you in these respects.  We welcome any
questions you may have about our comments or any other aspect of our review.  Feel free to call
us at the telephone numbers listed  at the end of this letter.
 Schedule 14A

1. We note your response to comment one in our letter dated April 16, 2009.  Please advise us
as to how your notice of intern et availability complies with the requirements in Rule 14a-
16.  For example, it does not appear to contai n all of the information required by Rule 14a-
16(c)(1) and contains supporting statements when Rule 14a-16(c)(3) specif ically states that
no supporting statements be included.  Please refer to Rule 14a-16 and SEC Release No.
34-56135 in your analysis.

Aron Izower, Esq.
Quigley Corporation April 24, 2009 Page 2   Reasons for the Solicitation, page 2

2. We note your response to comment six in our  letter dated April 16, 2009.  Please revise
your disclosure to include the support for your statements.
3. We note that the participants collectively own over 10% of th e shares outstanding.  Please
revise to include the information requ ired by Item 405 of Regulation S-K and
corresponding Item 7(b) of Schedule 14A.
 Proposal One—Election of  Directors, page 4

4. We note your statement that one or more Shareholder Nominees qualify as an audit
committee financial expert.  Please revi se to identify these individuals.
 What is a quorum, page 11

5. We note your response to comment 12 in our le tter dated April 16, 2009.  Please revise to
clearly state the effect of broker non-votes and abstentions on the quorum requirement.

Please direct any questions to me at ( 202) 551-3411.  You may also contact me via
facsimile at (202) 772-9203.  Please send all correspondence to us at the following ZIP code:  20549-3628.
                               Sincerely,
                                      Peggy Kim         S p e c i a l  C o u n s e l          Office of Mergers & Acquisitions